HOME >> MEDICINE >> NEWS
Serendipity versus planning - cancer drugs of the future?

Delegates at the European Breast Cancer Conference (EBCC-5) were given two examples of promising new drugs to watch in the future - raloxifene and lapatinib.

New anticancer drugs are usually developed specially for the job, but occasionally they are borrowed from another field of medicine, and applied speculatively in cancer. Tamoxifen was designed as an anti-oestrogen, based on the observation that at least a third of breast cancers depend on female sex hormones such as oestrogen for survival. Tamoxifen has shown to be an exceptionally effective molecule in cancer treatment; It was never planned to be a preventive agent, but so it has proved to be! It is now licensed to be used to prevent breast cancer in certain women at high risk of the disease.

Contrast this with raloxifene, a drug first developed to treat osteoporosis in women. A selective benzothiophene oestrogen receptor modulator (SERM), raloxifene binds to oestrogen receptors as a mixed oestrogen and anti-oestrogen effect. It functions as an oestrogen sometimes (in bones and on lipid metabolism) and as an anti-oestrogen in other target tissues (endometrium and breast). So, it has the potential for producing some of oestrogen's beneficial effects without producing its adverse effects. In a trial of its use in osteoporosis, it appeared to have another completely different effect, namely prevention of new hormone dependant breast cancers.

Results from the MORE (The Multiple Outcomes of Raloxifene Evaluation) study of 7,705 women that were randomised to raloxifene or placebo demonstrated that among postmenopausal women with osteoporosis, the risk of invasive breast cancer was decreased by 76% during three years of treatment with raloxifene.

Stronger evidence on the safety and efficacy of raloxifene is awaited from the STAR Trial. This trial includes almost 20,000 postmenopausal women in the US who are at increased risk of breast cancer to determine whether raloxifene is as e
'"/>

Contact: EBCC-5 Press Office
stephanie.makin@toniclc.com
33-493-928-402
Federation of European Cancer Societies
24-Mar-2006


Page: 1 2 3

Related medicine news :

1. Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention
2. Quality versus quantity -- transforming kidney transplant policy
3. Fixed versus growth intelligence mindsets: Its all in your head, Dweck says
4. Mechanism of black cohosh versus hot flashes revealed
5. IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
6. Adolescent condom use with casual versus main partners
7. Study shows rituximab effective in treating chronic graft-versus-host disease
8. Gap widens between optimal versus actual cholesterol levels
9. CT colonography versus colonoscopy for colorectal cancer
10. The economics of prescription drugs versus OTC
11. Inverse planning system improves brachytherapy treatment for prostate and other cancers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Serendipity versus planning cancer drugs the future

(Date:7/29/2015)... ... July 29, 2015 , ... Today marks a significant achievement in bringing new ... companies and is led by a group of experienced investors, has tapped into an ... their dollars to be a part of the fund. The Sofia Fund II ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline ... fall of 2015 on RFD-TV. , Fastline is dedicated to quality agricultural advertising, ... which contains the largest and freshest searchable agriculture equipment database in the world. ...
(Date:7/29/2015)... ... ... It is unique for a health center to dedicate a full-time medical ... is very hands on and resident oriented, and one to which Dr. Rennecker is ... and energy, as well as a strong commitment to helping seniors live longer, healthier ...
(Date:7/29/2015)... ... July 29, 2015 , ... TransFlip is an all new dynamic transition pack ... for FCPX, these transitions are easy to apply and modify for any skill-level user. ... over 60 preset styles, kinetic flipping panel animations are just a few clicks away. ...
(Date:7/29/2015)... ... July 29, 2015 , ... The New Foundation AZ recently ... the end will cost the 501(c) organization nearly $1 million, will both update the ... , “We took it down to the studs,” said Geraldine Leary, the New Foundation ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3
(Date:7/29/2015)... -- The Perinatal Quality Foundation (PQF) today announced a ... limitations and clinically appropriate interpretation of results of ... pregnant women and their healthcare providers. Quest Diagnostics ... of diagnostic information services, is the first commercial ... Through a comprehensive education and ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that ... broadcast news segment in Australia .  The ... following regulatory and reimbursement approval in that country. ... Australians living with diabetes. As a case in point, the ... for a 13 year old boy with Type 1 diabetes ...
(Date:7/29/2015)... July 29, 2015 Breckenridge Pharmaceutical, Inc. ... Nasal Solution, 0.1%. The U.S. Food and Drug Administration ... (ANDA), which is AB rated to Astelin®, a ... solution (nasal spray) is a $69 million dollar ... sales data.  Azelastine HCl Nasal Solution is indicated ...
Breaking Medicine Technology:Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3
Cached News: